CIK 0002096997 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Kailera Therapeutics, Inc.
Sign in to watch- Ticker
- KLRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 508-440-9475
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| No insider trades stored. | ||||||